Down-Regulating the High Level of 17-Beta-Hydroxysteroid Dehydrogenase 13 Plays a Therapeutic Role for Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, and there is no specific drug to treat it. Recent results showed that 17-beta-hydroxysteroid dehydrogenase type 13 (HSD17B13) is associated with liver diseases, but these conclusions are controversial. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meixi, Li, Jianrui, Li, Hu, Dong, Biao, Jiang, Jing, Liu, Nannan, Tan, Jiali, Wang, Xuekai, Lei, Lei, Li, Hongying, Sun, Han, Tang, Mei, Wang, Huiqiang, Yan, Haiyan, Li, Yuhuan, Jiang, Jiandong, Peng, Zonggen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146021/
https://www.ncbi.nlm.nih.gov/pubmed/35628360
http://dx.doi.org/10.3390/ijms23105544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146021/
https://www.ncbi.nlm.nih.gov/pubmed/35628360
http://dx.doi.org/10.3390/ijms23105544

Ejemplares similares